SPH Health Commerce

Shanghai Pharma Health Commerce Co., Ltd. (hereinafter referred to as "SPH Health Commerce") was established on March 18, 2015, as the new retail platform for prescription drugs under Shanghai Pharmaceuticals, leveraging the "Internet+" approach. SPH Health Commerce operates a new retail business model for prescription drugs centered on electronic prescription circulation, utilizing "Internet+" to assist the government and medical institutions in achieving the separation of medical services and pharmaceuticals. In August 2015 and March 2016, SPH Health Commerce completed its Series A and Series A+ funding rounds, respectively, with a registered capital of 1.333 billion yuan. Key shareholders include JD.com, SoftBank China, IDG, and the Shanghai Charity Foundation. SPH Health Commerce is committed to building the "Yi Yao" series of brands, forming a closed-loop value chain for new retail of prescription drugs that encompasses prescription acquisition and management, payment and rationality control, fulfillment and delivery, and value-added services for prescriptions and patients.SPH Health Commerce continues to innovate, extending along the pharmaceutical distribution value chain based on the needs of the government, hospitals, and patients. It aims to become China's leading public electronic prescription platform, the top specialty drug DTP network in China, and a leading provider of solutions for the separation of medical services and pharmaceuticals in China.